COVID-19 and leukaemia; what more do we know?

This webinar will explore the latest guidance and recommendations for leukaemia patients, including those who are immunocompromised and the clinically extremely vulnerable. Are there different recommendations for different groups of patients?

The aim of this webinar is to update on latest COVID-19 data across the leukaemia types:  vaccinations, responses, what does this mean in relation to protection, information about COVID-19 boosters and progress with anti-COVID-19 monoclonal antibody research trials for the immune compromised.

We will be joined by: 

  • Dr Helen Parry, National Institute for Health Research (NIHR), Birmingham University and Queen Elizabeth Hospital Birmingham. Helen is a clinical lecturer leading research into optimising vaccination strategies and minimising infection risk in patients with leukaemia

Webinar details

Date: Tuesday 28th September
Time: 4:30pm
Topic: COVID-19 and leukaemia; what more do we know?
Host: Leukaemia Care

How do I join the webinar? 

The webinar is being hosted on Zoom and Facebook, meaning you can choose a platform to suit you. Zoom is the best place to ask questions, but if you join via Facebook we will try and get all the questions sent over to our panel; however, please expect a delay.

Information on how to join via Zoom or Facebook is below. 

Watch via Zoom

To join via Zoom, all you need to do is register your attendance before the webinar starts. You will then receive an email inviting you to join the webinar on the day.

Watch via Facebook

To join via Facebook, all you need is a Facebook account. Once logged in head to Leukaemia Care’s Facebook page at 4:30pm on 28th September and find the live video (it will be at the top of our feed).

Book your place via Zoom here.

Join on Facebook on the day here.

Please note, we will not be able to give individual medical advice. You will be directed to your own clinical team if we cannot answer your question in the webinar.

Due to the large amount of registrants, we cannot guarantee that everyone’s questions will be answered, but we will try and do our best in the time frame that we have.

If you have any issues registering via Zoom or issues on the day, please get in touch by emailing advocacy@leukaemiacare.org.uk.

 

Book Now

Chronic Myelomonocytic Leukaemia (CMML)

Chronic myelomonocytic leukaemia (CMML) is a specific type of leukaemia which affects the myeloid-cell-producing stem cells.

Read More